Alfatek Systems is a privately held Indian startup in the 3D printing industry, established in 2012. It has garnered attention for its innovative work in 3D bio-printing technologies, particularly in the field of fabricating human skin, tissue models, and personalized medicine. The company has secured a significant seed investment from Brandshoots Ventures in September 2017. Alfatek Systems has built a strong customer base, including top corporate names such as ITC, Tata Steel, and L&T, as well as leading R&D institutions like AIIMS, IITs, and CSIR labs. They have also formed partnerships with renowned global 3D bio-printing companies like RegenHU, Cellink, and Manchester BioGels, solidifying their position as the largest 3D bio-printing company in India in terms of market share. The company's achievements have been recognized and publicized by prominent media outlets such as CNBC TV, Times of India, Dainik Jagran. They have also received recognition on the international stage, being invited by the Chinese Government to showcase their technologies. Additionally, the company's contribution to the field of 3D bio-printing is substantiated by their co-authorship in two journal publications in JMR, Cambridge, UK, and JPMPB, Philadelphia, USA. Their work has been cited in several international publications, further solidifying their impact in the industry. Alfatek Systems has completed over 80 3D printer installations throughout India and is actively collaborating with leading research teams in academia and industry.